Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]

被引:34
作者
Rossi, PG
Federici, A
Bartolozzi, F
Farchi, S
Borgia, P
Guasticchi, G
机构
[1] Agcy Publ Hlth, I-00198 Rome, Italy
[2] Univ Hosp, Rome, Italy
关键词
D O I
10.1186/1471-2458-5-139
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The major limit to colorectal cancer screening effectiveness is often lowcompliance. We studied the reasons for non compliance and determinants of compliance to faecal occult blood tests in Lazio, Italy. Methods: This is a case-control study nested within a trial that tested the effect of type of test and provider on colorectal cancer screening compliance. Non compliant trial subjects were classified as cases, and compliant subjects were classified as controls. We sampled 600 cases and 600 controls matched by their general practitioner, half were invited for screening at the hospital, and the other half directly at their general practitioner's office. Cases and controls answered questions on: distance from test provider, logistical problems, perception of colorectal cancer risk, confidence in screening efficacy, fear of results, presence of colorectal cancer in the family, and gastrointestinal symptoms. Results: About 31% of cases never received the letter offering free screening, and 17% of the sampled population had already been screened. The first reported reason for non-compliance was "lack of time" (30%); the major determinant of compliance was the distance from the test provider: odds ratio > 30 minutes vs < 15 minutes 0.3 (95% CI = 0.2 - 0.7). The odds ratio for lack of time was 0.16 (95% IC 0.1 - 0.26). The effect was stronger if the hospital (0.03 95% CI = 0.01 - 0.1) rather than the general practitioner (0.3 95% CI = 0.2 - 0.6) was the provider. Twenty-two percent of controls were accompanied by someone to the test. Conclusion: To increase compliance, screening programmes must involve test providers who are geographically close to the target population.
引用
收藏
页数:10
相关论文
共 27 条
[1]  
[Anonymous], 2001, STAT STAT SOFTW REL
[2]  
[Anonymous], 2000, HEALTH TECHNOL ASSES
[3]   PARTICIPATION IN FECAL OCCULT BLOOD SCREENING - A CRITICAL-REVIEW [J].
BLALOCK, SJ ;
DEVELLIS, BM ;
SANDLER, RS .
PREVENTIVE MEDICINE, 1987, 16 (01) :9-18
[4]   HEMOCCULT COMPLIANCE RATES AND REASONS FOR NON-COMPLIANCE [J].
BOX, V ;
NICHOLS, S ;
LALLEMAND, RC ;
PEARSON, P ;
VAKIL, PA .
PUBLIC HEALTH, 1984, 98 (01) :16-25
[5]  
Brunton Margaret, 2002, N Z Med J, V115, pU168
[6]   Profile of women not attending in the Swiss Mammography Screening Pilot Programme [J].
Bulliard, JL ;
de Landtsheer, JP ;
Levi, F .
BREAST, 2004, 13 (04) :284-289
[7]  
Farrands P A, 1984, Community Med, V6, P12
[8]   The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy) [J].
Federici, A ;
Rossi, PG ;
Bartolozzi, F ;
Farchi, S ;
Borgia, P ;
Guastcchi, G .
CANCER CAUSES & CONTROL, 2006, 17 (01) :45-52
[9]   The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial [J].
Federici, A ;
Rossi, PG ;
Borgia, P ;
Bartolozzi, F ;
Farchi, S ;
Gausticchi, G .
JOURNAL OF MEDICAL SCREENING, 2005, 12 (02) :83-88
[10]   Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy [J].
Federici, A ;
Rossi, PG ;
Bartolozzi, F ;
Farchi, S ;
Borgia, P ;
Guastcchi, G .
PREVENTIVE MEDICINE, 2005, 41 (01) :30-35